The Goff Symptom Index: A Tool for Earlier Ovarian Cancer Detection

What Is the Goff Symptom Index?

Ovarian cancer has long been called a "silent killer" because its early symptoms can be vague and easy to dismiss. But research led by Dr. Barbara Goff and her colleagues at the University of Washington changed how we think about that. Their work showed that ovarian cancer does produce symptoms -- they just need to be recognized.

The Goff Symptom Index, first published in 2007 in the journal Cancer, is a simple, validated tool designed to help identify women whose symptoms warrant further evaluation for possible ovarian cancer. It is not a diagnostic test or a screening tool, but rather a symptom-based triage tool that gives women and their healthcare providers a clearer picture of when symptoms deserve attention.

The Six Symptoms (Three Clusters)

The index focuses on symptoms that occur more than 12 times per month and have been present for less than one year -- meaning they are new and persistent, not occasional or lifelong.

| Cluster | Symptoms | |---------|----------| | Pelvic/Abdominal Pain | Pelvic pain, abdominal pain | | Abdominal Size/Bloating | Increased abdominal size, bloating | | Eating/Fullness | Difficulty eating, feeling full quickly |

A positive index means a woman has experienced one or more of these symptoms at the specified frequency and duration.

The Research Behind It

Dr. Goff's original study compared symptom reporting in 149 women with ovarian cancer against two control groups (women undergoing routine screening and women referred for pelvic ultrasound). The results were striking:

• Early-stage disease: The index detected 56.7% of stage I/II cancers
• Advanced-stage disease: The index detected 79.5% of stage III/IV cancers
• Specificity: 90% in women over 50, 86.7% in women under 50

Since then, the Goff Symptom Index has been externally validated in multiple studies across different populations. A major validation study published in the Journal of the National Cancer Institute reported:

• Sensitivity: 66.7% overall
• Specificity: 90.0% in women 50 and older

A 2020 systematic review of symptom-based tools found sensitivities ranging from 56.9% to 83.3% and specificities from 48.3% to 98.9% across different studies, confirming the tool's utility in clinical triage.

The Modified Goff Symptom Index (MGSI)

Recognizing that no tool is perfect, researchers developed a Modified Goff Symptom Index that adds:

• Urinary urgency or frequency
• Loss of appetite
• Unexplained weight loss

The modified version has shown improved sensitivity -- 71.6% to 86.3% in various studies -- while maintaining strong specificity.

What the Goff Index Can and Cannot Do

What It Can Do: - Help women recognize when persistent symptoms need medical attention - Support primary care providers in deciding who needs further evaluation - Provide a structured, evidence-based framework for symptom discussion - Reduce the risk of symptoms being dismissed as "normal" or "just stress"

What It Cannot Do: - Diagnose ovarian cancer (only imaging and biopsy can do that) - Rule out ovarian cancer if symptoms are absent (sensitivity is not 100%) - Replace clinical judgment or a thorough medical workup - Serve as a population-wide screening test

Why This Matters for Underserved Communities

Ovarian cancer does not affect all women equally. Black women are more likely to be diagnosed at later stages and have higher mortality rates than White women, even when income and insurance are accounted for. Symptom awareness plays a critical role in this disparity.

When symptoms are dismissed or attributed to other causes, diagnosis is delayed. Tools like the Goff Symptom Index give women a way to track and describe their symptoms in a structured way -- a small but meaningful step toward catching ovarian cancer earlier, especially in communities where healthcare concerns are more likely to be overlooked.

How to Use the Goff Symptom Index

If you are concerned about ovarian cancer, here is how the Goff Index can help guide your conversation with a healthcare provider:

Step 1: Track your symptoms for several weeks. Note when they occur and how often.

Step 2: Ask yourself: - Have I had pelvic or abdominal pain more than 12 times this month? - Has my abdomen felt larger or more bloated than usual more than 12 times this month? - Have I felt full quickly or had trouble eating more than 12 times this month?

Step 3: If any of these symptoms are new (started in the past year), persistent, and happening this frequently, bring them to your provider's attention. Mention the Goff Symptom Index if it helps frame the conversation.

Step 4: If your provider recommends further evaluation, that may include a pelvic exam, transvaginal ultrasound, or the CA-125 blood test. These tests, combined with symptom assessment, give the most complete picture.

The Bottom Line

The Goff Symptom Index is a valuable tool, not a crystal ball. It gives women a clear, research-backed way to recognize symptom patterns that deserve attention. In a disease where every month counts, knowing what to watch for -- and having the language to describe it -- can make a real difference.

Knowledge is power. Track your symptoms. Trust your body. Speak up.

---

Sources - Goff BA, Mandel LS, Drescher CW, et al. Development of an ovarian cancer symptom index. Cancer. 2007;109(2):221-227. - Rossing MA, Wicklund KG, Cushing-Haugen KL, Weiss NS. Predictive value of symptoms for early detection of ovarian cancer. J Natl Cancer Inst. 2010;102(4):222-229. - Andersen MR, Goff BA, et al. Use of a symptom index, CA-125, and HE4 to predict ovarian cancer. Gynecologic Oncology. 2017;144(1):148-153. - Ebell MH, Culp MB, et al. A systematic review of symptom-based tools for the detection of ovarian cancer. Cancers. 2020;12(12):3686. - Shetty V, Pandey D, et al. Modified Goff Symptom Index: A simple triage tool for ovarian malignancy. Journal of Clinical and Diagnostic Research. 2019.